Copyright
        ©The Author(s) 2020.
    
    
        World J Exp Med. Apr 27, 2020; 10(3): 26-40
Published online Apr 27, 2020. doi: 10.5493/wjem.v10.i3.26
Published online Apr 27, 2020. doi: 10.5493/wjem.v10.i3.26
            Table 1 Clinical and pathological characteristics of the experimental population, n (%)
        
    | Patient demographics | No neoadjuvant chemotherapy, n = 10 | Neoadjuvant chemotherapy, n = 11 | P value | 
| Age, yr | 49 ± 6 | 49 ± 7 | 1.000 | 
| Stage of cancer | |||
| 0 | 2 (9.5) | 0 (0) | 0.2143 | 
| IA | 6 (28.5) | 2 (9.5) | 0.0805 | 
| IIA | 1 (5) | 4 (19) | 0.3108 | 
| IIB | 1 (5) | 2 (9.5) | 1.000 | 
| IIIA | 0 (0) | 3 (14) | 0.2143 | 
| Menopausal | 4 (19) | 5 (24) | 1.000 | 
| Multiparous | 10 (48) | 9 (43) | 0.4762 | 
| ER+ | 9 (43) | 8 (38) | 0.5865 | 
| PR+ | 10 (48) | 5 (24) | 0.0124 | 
| Her2+ | 3 (14) | 6 (28.5) | 0.3870 | 
| Tobacco | 3 (14) | 1 (5) | 0.3108 | 
- Citation: Hagaman AR, Zhang P, Koko KR, Nolan RS, Fromer MW, Gaughan J, Matthews M. Isolation and identification of adipose-derived stromal/stem cells from breast cancer patients after exposure neoadjuvant chemotherapy. World J Exp Med 2020; 10(3): 26-40
- URL: https://www.wjgnet.com/2220-315x/full/v10/i3/26.htm
- DOI: https://dx.doi.org/10.5493/wjem.v10.i3.26

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        